The influences of α-hemolytic Streptococcus on class switching and complement activation of human tonsillar cells in IgA nephropathy

Author(s):  
Muyao Ye ◽  
Chang Wang ◽  
Ling Li ◽  
Qiulan Zhao ◽  
Youming Peng ◽  
...  
2019 ◽  
Author(s):  
Huining Li ◽  
Dan Kong ◽  
Guodong Yao ◽  
Yang Xu ◽  
Yan Cao ◽  
...  

1987 ◽  
Vol 32 (6) ◽  
pp. 838-844 ◽  
Author(s):  
Abdalla Rifai ◽  
Ann Chen ◽  
Hirokazu Imai

Author(s):  
Min Wei ◽  
Wei-yi Guo ◽  
Bo-yang Xu ◽  
Su-fang Shi ◽  
Li-jun Liu ◽  
...  

Background and objectives: IgA nephropathy is the most common primary glomerulonephritis worldwide. Previous research demonstrated that collectin11, an initiator of complement lectin pathway, was involved in both acute kidney injury and chronic tubulointerstitial fibrosis. Here, we investigated the potential role of collectin11 in the pathogenesis of IgA nephropathy. Design, setting, participants, and measurements: The deposition of collectin11 and other complement proteins was detected in glomeruli of 60 participants with IgA nephropathy by immunofluorescence. In vitro, human mesangial cells were treated with IgA1-containing immune complexes derived from participants with IgA nephropathy. Then, the expression of collectin11 in mesangial cells was examined by RT-qPCR and immunofluorescence. The codeposition of collctin11 with IgA1 or C3 on mesangial cells was detected by immunofluorescence and proximity ligation assays. Results: 37% participants with IgA nephropathy (22/60) showed codeposition of collectin11 with IgA in the glomerular mesangium. Using an injury model of mesangial cells, we demonstrated that IgA1-immune complexes derived from participants with IgA nephropathy increased the secretion of collectin11 in mesangial cells with the subsequent deposition of collectin11 on the cell surface via the interaction with deposited IgA1-immune complexes. In vitro, we found that collectin11 bound to IgA1-immune complexes in a dose-dependent but calcium-independent manner. Furthermore, deposited collectin11 initiated the activation of complement and accelerated the deposition of C3 on mesangial cells. Conclusions: In situ-produced collectin11 by mesangial cells might play an essential role in kidney injury in a subset of patients with IgA nephropathy through the induction of complement activation.


PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e108723 ◽  
Author(s):  
Ting Meng ◽  
Xiaozhao Li ◽  
Xiang Ao ◽  
Yong Zhong ◽  
Rong Tang ◽  
...  

2017 ◽  
Vol 37 (3) ◽  
pp. 320-329
Author(s):  
Alfons Segarra-Medrano ◽  
Clara Carnicer-Caceres ◽  
Naiara Valtierra-Carmeno ◽  
Irene Agraz-Pamplona ◽  
Natalia Ramos-Terrades ◽  
...  

2019 ◽  
Vol 49 (1) ◽  
pp. 81-92 ◽  
Author(s):  
Preeti Chandra

Complement activation occurs in many glomerular diseases, the exact pathway(s) of activation has been studied in detail in some diseases but not in all. C4d is generated by the activation of classical and lectin pathways, and its presence can point to the activation of either of these pathways. This review aims to summarize the available data with regard to the deposition of glomerular C4d in native kidney biopsies in different glomerular pathologies that may be useful for future research into the role of complement activation in glomerular diseases. While there is more information on C4d in certain diseases (e.g., Immunoglobulin A (IgA) nephropathy), there is scant data in other diseases (such as focal segmental glomerulosclerosis).


Author(s):  
Nicholas R. Medjeral-Thomas ◽  
H. Terence Cook ◽  
Matthew C. Pickering

AbstractIgA nephropathy pathogenesis is incompletely understood, and this limits the development of disease-specific biomarkers and effective therapies. Evidence of complement activity in IgA nephropathy is well established. However, a growing body of research indicates complement activity is an important contributor to IgA nephropathy pathology. In particular, multiple associations have been identified between complement alternative, lectin and terminal pathway proteins and IgA nephropathy severity. Recently, we have also gained insight into possible mechanisms that could link glomerular IgA deposition, complement activity, glomerular inflammation and disease severity. Ongoing clinical trials of therapeutic complement inhibitors will provide insight into the importance of complement activity to IgA nephropathy pathogenesis. Further research into mechanisms of complement activity is essential to improving our understanding and management of patients with IgA nephropathy.


2012 ◽  
Vol 181 (4) ◽  
pp. 1338-1347 ◽  
Author(s):  
Azusa Hashimoto ◽  
Yusuke Suzuki ◽  
Hitoshi Suzuki ◽  
Isao Ohsawa ◽  
Rhubell Brown ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document